1Creager M A. Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events[J]. Vasc Med, 1998,3 : 257-260.
2Balamuthusamy S,Arora R. Hematologic adverse effects of clopidogrel[J]. Am J Ther,2007,14 : 106-112.
3Uz O,Kardeco glu E,Aparci M,Yi giner O,Icilak Z,Ozmen N. Nonfatal aplastic anemia associated with clopidogrel[J]. Anadolu Kardiyol Derg, 2010,10 : 291.
4Andres E,PerrinAE,AltM, Goichot B,Schlienger J L. Febrile pancytopenia associated with clopidogrel[J]. Arch Intern Med, 2001,161:125.
5Matthews K E, Hameed B,Jawed S. Acute severe pancytopenia associated with elopidogrel[J]. Br J Hosp Med (Lond), 2009, 70:52.
6Su C H,Tsai C F,Ueng K C,Shiao P G,Lin C S,Chen K S,et al. Clopidogrel-assoeiated severe isolated thrombocytopenia--a case report[J]. Acta Cardiol Sin, 2004,20 : 182-186.
7Schafer A, Eigenthaler M, Bauersachs J. Severe neutropenia under elopidogrel treatment three weeks after coronary stenting [J]. Thromb Haemost, 2007,97 : 317-318.
10Almsherqi Z A,McLachlan C S,Sharef S M. Non-bleeding side effects of clopidogrel:have large multi-center clinical trials underestimated their incidence[J]? Int J Cardiol, 2007,117 :415- 417.
